Insights into mechanisms of antiarrhythmic drug action from experimental models of atrial fibrillation

Journal of Cardiovascular Electrophysiology

Volumn 8, Issue 4, 1997, Pages 469-480

  Nattel, Stanley ^a   Bourne, Gerald ^b   Talajic, Mario ^b  

^a MONTREAL HEART INSTITUTE   (Canada)

^b NONE

Author keywords

antiarrhythmic drugs; atrial fibrillation; cardiac arrhythmias; flecainide; heterogeneity; reentry; refractory period; sotalol; wavelength

Indexed keywords

ANTIARRHYTHMIC AGENT; FLECAINIDE; PROCAINAMIDE; PROPAFENONE; SOTALOL;

ANIMAL CELL; ANIMAL TISSUE; DOG; EXTRASYSTOLE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART MUSCLE REFRACTORY PERIOD; HEART VENTRICLE REMODELING; HISTORY OF MEDICINE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SPECTRAL SENSITIVITY;

EID: 0030948569     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8167.1997.tb00813.x     Document Type: Review

References (53)

1. Nattel S, Hadjis T, Talajic M: The treatment of atrial fibrillation: An evaluation of drug therapy, electrical modalities and therapeutic considerations. Drugs 1994;48:345-371.
2. Kirchhof C, Wijffels M, Brugada J, et al: Mode of action of a new class IC drug (ORG 7797) against atrial fibrillation in conscious dogs. J Cardiovasc Pharmacol 1991;17:116-124.
3. Josephson ME: Clinical Cardiac Electrophysiology: Techniques and Interpretations. Lea & Febiger, Philadelphia, 1993, pp. 275-310.
4. Cox JL, Canavan TE, Schuessler RB, et al: The surgical treatment of atrial fibrillation: II. Intraoperative electrophysiologic mapping and description of the electrophysiologic basis of atrial flutter and atrial fibrillation. J Thorac Cardiovasc Surg 1991;101:406-426.
5. Ortiz J, Niwano S, Abe H, et al: Mapping the conversion of atrial flutter to atrial fibrillation and atrial fibrillation to atrial flutter: Insights into mechanisms. Circ Res 1994;74:882-894.
6. Wang Z, Pagé P, Nattel S: Mechanisms of flecainide's antiarrhythmic action in experimental atrial fibrillation. Circ Res 1992;71:271-287.
7. Wang J, Bourne GW, Wang Z, et al: Comparative mechanisms of antiarrhythmic drug action in experimental atrial fibrillation: The importance of use-dependent effects on refractoriness. Circulation 1993;88:1030-1044.
8. Wang J, Feng J, Nattel S: Class III antiarrhythmic drug action in experimental atrial fibrillation: Differences in reverse use dependence and effectiveness between d-sotalol and the new antiarrhythmic drug ambasilide. Circulation 1994;90:2032-2040.
9. Salmon DR, McPherson DD, Augustine DE, et al: A canine model of chronic atrial fibrillation: Echocardiographic and electrocardiographic validation. (Abstract) Circulation 1985;72(Suppl III):III-250.
10. Wijffels MCEF, Kirchhof CJHJ, Dorland R, et al: Atrial fibrillation begets atrial fibrillation: A study in awake chronically instrumented goats. Circulation 1995;92:1954-1968.
11. Morillo CA, Klein GJ, Jones DL, et al: Chronic rapid atrial pacing: Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation 1995;91:1588-1595.
12. Garrey WE: The nature of fibrillary contraction of the heart: Its relation to tissue mass and form. Am J Physiol 1914;33:397-414.
13. Moe GK, Rheinboldt WC, Abildskov JA: A computer model of atrial fibrillation. Am Heart J 1964;67:200-220.
14. Moe GK, Abildskov JA: Experimental and laboratory reports: Atrial fibrillation as a self-sustaining arrhythmia independent of focal discharge. Am Heart J 1959;58:59-70.
15. Moe GK: On the multiple wavelet hypothesis of atrial fibrillation. Arch Int Pharmacodyn Ther 1962;140:183-188.
16. Allessie MA, Bonke FIM, Schopman FJG: Circus movement in rabbit atrial muscle as a mechanism of tachycardia: III. The "leading circle" concept: A new model of circus movement in cardiac tissue without the involvement of an anatomic obstacle. Circ Res 1977; 41:9-18.
17. Wiener N, Rosenblueth A: The mathematical formulation of the problem of conduction of impulses in a network of connected excitable elements, specifically in cardiac muscle. Arch Inst Cardiol Mex 1946;16:205-265.
18. Rensma PL, Allessie MA, Lammers WJEP, et al: Length of excitation wave and susceptibility to reentrant atrial arrhythmias in normal conscious dogs. Circ Res 1988;62:395-410.
19. Kirchhof C, Wijffels M, Brugada J, et al: Mode of action of a new class Ic drug (ORG 7797) against atrial fibrillation in conscious dogs. J Cardiovasc Pharmacol 1991;17:116-124.
20. Winfree AT: Varieties of spiral wave behavior: An experimentalist's approach to the theory of excitable media. Chaos 1991;1:303-334.
21. Cabo C, Pertsov AM, Baxter WT, et al: Wave-front curvature as a cause of slow conduction and block in isolated cardiac muscle. Circ Res 1994;75:1014-1028.
22. Allessie M, Kirchhof C, Scheffer GJ, et al: Regional control of atrial fibrillation by rapid pacing in conscious dogs. Circulation 1991;84:1689-1697.
23. Vaughan Williams EM: A classification of antiarrhythmic actions reassessed after a decade of new drugs. J Clin Pharmacol 1984;24:129-147.
24. Harrison DC: Antiarrhythmic drug classification: New science and practical applications. Am J Cardiol 1985;56:185-187.
25. Wang Z, Pelletier LC, Talajic M, et al: Effects of flecainide and quinidine on human atrial action potentials: Role of rate-dependence and comparison with guinea pig, rabbit, and dog tissues. Circulation 1990; 82:274-283.
26. Bennett MA, Pentecost BL: The pattern of onset and spontaneous cessation of atrial fibrillation in man. Circulation 1970;41:981-988.
27. Hohnloser SH, van de Loo A, Baedeker F: Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: Prospective comparison of sotalol versus quinidine. J Am Coll Cardiol 1995;26:852-858.
28. Wang J, Liu L, Feng J, et al: Regional and functional factors determining the induction and maintenance of atrial fibrillation in dogs. Am J Physiol (Heart Circ Physiol) 1996;271:H148-H158.
29. Liu L, Nattel S: Sympathetic stimulation decreases wavelength for atrial reentry but fails to promote atrial fibrillation in dogs: Importance of heterogeneity in refractoriness. (Abstract) PACE 1996;19(Pt II):643.
30. Sato S, Yamauchi S, Schuessler RB, et al: The effect of augmented atrial hypothermia on atrial refractory period, conduction, and atrial flutter/fibrillation in the canine heart. J Thorac Cardiovasc Surg 1992;104:297-306.
31. Alessi R, Nusynowitz M, Abildskov JA, et al: Nonuniform distribution of vagal effects on the atrial refractory period. Am J Physiol 1958;194:406-410.
32. Ninomiya I: Direct evidence of nonuniform distribution of vagal effects on dog atria. Circ Res 1966; 19:576-583.
33. Wang Z, Feng J, Nattel S: Idiopathic atrial fibrillation in dogs: Electrophysiologic determinants and mechanisms of antiarrhythmic action of flecainide. J Am Coll Cardiol 1995;26:277-286.
34. Ramdat Misier AR, Opthof T, van Hemel NM, et al: Increased dispersion of "refractoriness" in patients with idiopathic paroxysmal atrial fibrillation. J Am Coll Cardiol 1992;19:1531-1535.
35. Abildskov JA: Induced termination of fibrillation. J Cardiovasc Electrophysiol 1996;7:71-81.
36. Attuel P, Childers R, Cauchemez B, et al: Failure in the rate adaptation of the atrial refractory period: Its relationship to vulnerability. Int J Cardiol 1982;2:179-197.
37. Gaspo R, Bosch RF, Talajic M, et al: Mechanisms underlying tachycardia-induced propensity to atrial fibrillation (AF) in a chronic dog model. (Abstract) Can J Cardiol 1996;12(Suppl E):165E.
38. Yue L, Feng J, Gaspo R, et al: Ionic remodelling underlying tachycardia-induced atrial fibrillation in dogs. (Abstract) Circulation 1996;94:I-592.
39. Leistad E, Aksnes G, Verburg E, et al: Atrial contractile dysfunction after short-term atrial fibrillation is reduced by verapamil but increased by BAY K8644. Circulation 1996;93:1747-1754.
40. Tieleman RG, de Langen CDJ, van der Woude HJ, et al: Reduction of electrical remodeling of the atrium by verapamil. (Abstract) Circulation 1995;92(Suppl I):I-754.
41. Ferguson TB Jr, Schuessler RB, Hand DE, et al: Lessons learned from computerized mapping of the atrium. Surgery for atrial fibrillation and atrial flutter. J Electrocardiol 1993;26:210-219.
42. Konings KTS, Kirchhof CJHJ, Smeets JRLM, et al: High-density mapping of electrically induced atrial fibrillation in humans. Circulation 1994;89:1665-1680.
43. Cox JL, Schuessler RB, Boineau JP: The surgical treatment of atrial fibrillation: I. Summary of the current concepts of the mechanisms of atrial flutter and atrial fibrillation. J Thorac Cardiovasc Surg 1991;101:402-405.
44. Cox JL, Schuessler RB, D'Agostino HJ Jr, et al: The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure. J Thorac Cardiovasc Surg 1991;101:569-583.
45. Asano Y, Saito J, Matsumoto K, et al: On the mechanism of termination and perpetuation of atrial fibrillation. Am J Cardiol 1992;69:1033-1038.
46. Botteron GW, Smith JM: Quantitative assessment of the spatial organization of atrial fibrillation in the intact human heart. Circulation 1996;93:513-518.
47. Botteron GW, Smith JM: A technique for measurement of the extent of spatial organization of atrial activation during atrial fibrillation in the intact human heart. IEEE Trans Biomed Eng 1995;42:579-586.
48. Coumel P: Paroxysmal atrial fibrillation: A disorder of autonomic tone? Eur Heart J 1994;15(Suppl A):9-16.
49. Coumel P: Fibrillation auriculaire paroxystique: le rôle du système nerveux autonome. Arch Mal Coeur 1994; 87:55-62.
50. Botteron GW, Smith JM: Spatial organization of electrical activation during atrial fibrillation in the intact human heart and its response to antiarrhythmic drug therapy. (Abstract) PACE 1994;17(Pt II):750.
51. Brugada J, Gürsoy S, Brugada P, et al: Cibenzoline transforms random re-entry into ordered re-entry in the atria. Eur Heart J 1993;14:267-272.
52. Suttorp MJ, Kingma JH, Lie-A-Huen L, et al: Intravenous flecainide versus verapamil for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. Am J Cardiol 1989;63:693-696.
53. Kondili A, Kastrati A, Popa Y: Comparative evaluation of verapamil, flecainide and propafenone for the acute conversion of atrial fibrillation to sinus rhythm. Wien Klin Wochenschr 1990;102:510-513.